Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective

Most screening programs to identify individuals at risk for type 1 diabetes have targeted relatives of people living with the disease to improve yield and feasibility. However, ∼90% of those who develop type 1 diabetes do not have a family history. Recent successes in disease-modifying therapies to...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Diabetes (New York, N.Y.) Ročník 71; číslo 4; s. 610
Hlavní autori: Sims, Emily K, Besser, Rachel E J, Dayan, Colin, Geno Rasmussen, Cristy, Greenbaum, Carla, Griffin, Kurt J, Hagopian, William, Knip, Mikael, Long, Anna E, Martin, Frank, Mathieu, Chantal, Rewers, Marian, Steck, Andrea K, Wentworth, John M, Rich, Stephen S, Kordonouri, Olga, Ziegler, Anette-Gabriele, Herold, Kevan C
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 01.04.2022
Predmet:
Autoantibodies
Diabetes Mellitus, Type 1 - diagnosis
Diabetes Mellitus, Type 1 - epidemiology
Humans
Mass Screening
ISSN:1939-327X, 1939-327X
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Most screening programs to identify individuals at risk for type 1 diabetes have targeted relatives of people living with the disease to improve yield and feasibility. However, ∼90% of those who develop type 1 diabetes do not have a family history. Recent successes in disease-modifying therapies to impact the course of early-stage disease have ignited the consideration of the need for and feasibility of population screening to identify those at increased risk. Existing population screening programs rely on genetic or autoantibody screening, and these have yielded significant information about disease progression and approaches for timing for screening in clinical practice. At the March 2021 Type 1 Diabetes TrialNet Steering Committee meeting, a session was held in which ongoing efforts for screening in the general population were discussed. This report reviews the background of these efforts and the details of those programs. Additionally, we present hurdles that need to be addressed for successful implementation of population screening and provide initial recommendations for individuals with positive screens so that standardized guidelines for monitoring and follow-up can be established.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1939-327X
1939-327X
DOI:10.2337/dbi20-0054